Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patents bile acid receptor antagonists Aug. 14, 2017
Beijing Marino Biotechnology describes a transgenic lymphocyte construct identifying EGFRvIII Aug. 11, 2017
Yeda Research & Development patents protein LYRIC/transcription factor p65 interaction inhibitors Aug. 11, 2017